Efficient, Effective, & Economical Lyophilization Services from BIOLYPH
BIOLYPH is excited to exhibit at ADLM 2025 in Chicago
Minneapolis, MN, USA – July 23, 2025 – BIOLYPH, the leading lyophilization service provider for the IVD, RUO, and Life Science industries, is excited to exhibit at ADLM 2025 in Chicago for the thirtieth time.
BIOLYPH transforms unstable liquid reagents into precise, room-temperature stable lyophilized aliquots called LyoSpheres™ and packages them inside virtually any device. For over 32 years, countless IVD assay developers and life science reagent manufacturers have trusted BIOLYPH’s Efficient, Effective, and Economical lyophilization services.
As the only dedicated, pure-play provider of lyophilization services, BIOLYPH provides a seamless process from Proof-of-Concept through Production and flexibly scales to meet the needs of our clients at any volume—from small Proof-of-Concept batches to full Production-scale, multi-million reaction orders.
By leveraging decades of expertise in Formulation Analysis, Excipient Formulation, Lyophilization, and Packaging, BIOLYPH compresses our clients’ development timelines, maximizes the quality, consistency, and value of their products, and helps them delight their customers.
During ADLM, BIOLYPH will have team members available in booth #4015 to discuss applications, answer questions, and lay out the straightforward process to achieve functional, stable lyophilized assays, reagents, and controls in less than three weeks.
BIOLYPH transforms unstable liquid reagents into precise, room-temperature stable lyophilized aliquots called LyoSpheres™ and packages them inside virtually any device. For over 32 years, countless IVD assay developers and life science reagent manufacturers have trusted BIOLYPH’s Efficient, Effective, and Economical lyophilization services.
As the only dedicated, pure-play provider of lyophilization services, BIOLYPH provides a seamless process from Proof-of-Concept through Production and flexibly scales to meet the needs of our clients at any volume—from small Proof-of-Concept batches to full Production-scale, multi-million reaction orders.
By leveraging decades of expertise in Formulation Analysis, Excipient Formulation, Lyophilization, and Packaging, BIOLYPH compresses our clients’ development timelines, maximizes the quality, consistency, and value of their products, and helps them delight their customers.
During ADLM, BIOLYPH will have team members available in booth #4015 to discuss applications, answer questions, and lay out the straightforward process to achieve functional, stable lyophilized assays, reagents, and controls in less than three weeks.
Category Press Releases